Body Text
Competitive advantage
Fundamental and multidisciplinary expertise in:
- Synthetic and natural biomaterials
- Blood vessel cell surface and extracellular matrix molecules
- Recombinant protein expression
- Biochemical, biophysical and cell-based functional assays
- In vivo models
Impact
- Developing next generation biomaterials that interface with the body to direct blood vessel and tissue repair
Successful outcomes
- IP portfolio in methods to produce signalling molecules
- Preclinical testing for novel vascular graft coating
- Preclinical testing for diabetic wound healing
- Coatings for prolonged platelet storage
Capabilities and facilities
- State-of-the-art preclinical biomaterial and biological molecule development and testing laboratories encompassing in vitro and in vivo analyses
Our partners
- Synedgen Inc
- TriCol Biomedical
- Diabetes Australia
- Australian Red Cross Blood Service